Zai Lab Limited today announced clinical data indicating zocilurtatug pelitecan (zoci, formerly ZL-1310), a DLL3-targeting antibody-drug conjugate (ADC), provides rapid and robust intracranial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results